Stemcells, Inc.

Stemcells, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

StemCells, Inc. is currently engaged in clinical development of its HuCNS-SC® platform technology (purified human neural stem cells) as a potential treatment for both neurological and retinal disorders. Top-line data from the Company's Phase I/II clinical trial in thoracic spinal cord injury (SCI) showed measurable gains involving multiple sensory modalities and segments, including the conversion of two of seven patients enrolled in the study with complete injuries to incomplete injuries, post-transplant. The Company's Pathway™ Study, a Phase II proof-of-concept trial in cervical SCI is actively enrolling at eight sites and interim data from the first cohort of six patients is anticipated to be forthcoming in Q4 2015. StemCells, Inc. has also completed its Phase I/II clinical trial in GA-AMD. Top-line results from this study show a positive safety profile and favorable preliminary efficacy data related to visual acuity and contrast sensitivity. The Company's Radiant™ Study, a Phase II proof-of-concept trial in GA-AMD is now enrolling at the first of approximately twenty U.S. sites expected to participate. In a Phase I clinical trial in Pelizaeus-Merzbacher disease (PMD), a fatal myelination disorder in children, the Company showed preliminary evidence of progressive and durable donor-derived myelination by MRI.

Company Details

Employees
74
Founded
-
Address
7707 Gateway Blvd.,
Phone
1 (510) 456-4000
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
StemCells21.
HQ
Newark, Cafilfornia
Looking for a particular Stemcells, Inc. employee's phone or email?

Stemcells, Inc. Questions

News

Human Neural Stem Cells Induce Functional Myelination in Mice with Severe Dysmyelination - Science | AAAS

Human Neural Stem Cells Induce Functional Myelination in Mice with Severe Dysmyelination Science | AAAS

RichSource Stem Cells, Inc. Announces Non-Invasive Breakthrough Product RICHGEN - BioInformant

RichSource Stem Cells, Inc. Announces Non-Invasive Breakthrough Product RICHGEN BioInformant

Sprouting a career in regenerative medicine - Science | AAAS

Sprouting a career in regenerative medicine Science | AAAS

If You Can’t Pass This Quiz, You Shouldn’t Have Graduated From High School - BuzzFeed

If You Can’t Pass This Quiz, You Shouldn’t Have Graduated From High School BuzzFeed

Top Stemcells, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant